Further investigation into the prognostic implications of the expression of the 11 genes revealed a correlation between high expression levels of ATP7B, DBT, FDX1, PDHA1, and PDHB and poor prognosis in AML patients. The gene discussed is FDX1; the disease is acute myeloid leukemia.